MedTrace Logo

A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure

NCT00565994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2010-09-28

No results posted yet for this study

Summary

We hope to study components within the blood that may predict success, failure or other associated complications in relation to the type of vascular access being used.

Conditions

  • Chronic Renal Failure

Interventions

PROCEDURE

Blood Draw

For patients undergoing routine hemodialysis for chronic renal failure, 5-10 ml of blood will be removed from the dialysis tubing during vascular access. All other subjects will have 5-10 ml of blood drawn by routine venipuncture.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • William C Jennings, MD · University of Oklahoma-Tulsa

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00565994 on ClinicalTrials.gov